Literature DB >> 17105482

Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonists.

Minying Cai1, Eva V Varga, Magda Stankova, Alexander Mayorov, Joseph W Perry, Henry I Yamamura, Dev Trivedi, Victor J Hruby.   

Abstract

Melanocortin hormones and neurotransmitters regulate a vast array of physiologic processes by interacting with five G-protein-coupled melanocortin receptor types. In the present study, we have systematically studied the regulation of individual human melanocortin receptor wild subtypes using a synthetic rhodamine-labeled human melanotropin agonist and antagonist, arrestins fused to green fluorescent protein in conjunction with two-photon fluorescence laser scanning microscopy and confocal microscopy. Stimulation of the melanocortin receptors by its cognate agonist triggered rapid arrestin recruitment and receptor internalization for all four human melanocortin receptors examined. Antagonists-bound melanocortin receptors, on the other hand, did not recruit beta-arrestins, and remained in the cell membrane even after long-term (30 min) treatment. Agonist-mediated internalization of all melanocortin receptor subtypes was sensitive to inhibitors of clathrin-dependent endocytosis, but not to caveolae inhibitors. In summary, agonist-mediated internalization of all subtypes of melanocortin receptors are dependent upon beta-arrestin-mediated clathrin-coated pits, whereas, beta-arrestin-2 conjugated green fluorescence protein (beta-arrestin-2-GFP) recruitment is not dependent on protein kinase A activation. Real time two-photon fluorescence laser scanning microscopy is a most powerful tool to study the dynamic processes in living cells and tissues, without inflicting significant and often lethal damage to the specimen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105482      PMCID: PMC2547351          DOI: 10.1111/j.1747-0285.2006.00432.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  51 in total

Review 1.  Partial agonists and G protein-coupled receptor desensitization.

Authors:  R B Clark; B J Knoll; R Barber
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

Review 2.  [The central melanocortin system and its role in energy homeostasis].

Authors:  R D Cone
Journal:  Ann Endocrinol (Paris)       Date:  1999-03       Impact factor: 2.478

Review 3.  Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone.

Authors:  N A Tritos; E Maratos-Flier
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

4.  Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases.

Authors:  F Dicker; U Quitterer; R Winstel; K Honold; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 5.  G protein-coupled receptor kinases.

Authors:  J A Pitcher; N J Freedman; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.

Authors:  Minying Cai; Alexander V Mayorov; Christopher Cabello; Magda Stankova; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

8.  Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells.

Authors:  Y Okamoto; H Ninomiya; S Miwa; T Masaki
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

9.  Role of the CNS melanocortin system in the response to overfeeding.

Authors:  M M Hagan; P A Rushing; M W Schwartz; K A Yagaloff; P Burn; S C Woods; R J Seeley
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

10.  Exploring the stereostructural requirements of peptide ligands for the melanocortin receptors.

Authors:  Victor J Hruby; Minying Cai; Paolo Grieco; Guoxia Han; Malcolm Kavarana; Dev Trivedi
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

View more
  15 in total

1.  Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors.

Authors:  Wei Lu; Chiyi Xiong; Rui Zhang; Lifang Shi; Miao Huang; Guodong Zhang; Shaoli Song; Qian Huang; Gang-Yu Liu; Chun Li
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

2.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Natalie M Barkey; Narges K Tafreshi; Jatinder S Josan; Channa R De Silva; Kevin N Sill; Victor J Hruby; Robert J Gillies; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2011-11-10       Impact factor: 7.446

Review 3.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

4.  Mechanisms of melanocortin-2 receptor (MC2R) internalization and recycling in human embryonic kidney (hek) cells: identification of Key Ser/Thr (S/T) amino acids.

Authors:  Simon Roy; Sébastien Jean Roy; Sandra Pinard; Louis-Daniel Taillefer; Mohamed Rached; Jean-Luc Parent; Nicole Gallo-Payet
Journal:  Mol Endocrinol       Date:  2011-09-15

5.  Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Robert C Speth; Adam T Zarth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2018-05-09       Impact factor: 7.446

Review 6.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

7.  Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1.

Authors:  Mikhail O Durymanov; Elena A Beletkaia; Alexey V Ulasov; Yuri V Khramtsov; Georgiy A Trusov; Nikita S Rodichenko; Tatiana A Slastnikova; Tatiana V Vinogradova; Natalia Y Uspenskaya; Eugene P Kopantsev; Andrey A Rosenkranz; Eugene D Sverdlov; Alexander S Sobolev
Journal:  J Control Release       Date:  2012-09-01       Impact factor: 9.776

8.  Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.

Authors:  Natalie M Barkey; Christian Preihs; Heather H Cornnell; Gary Martinez; Adam Carie; Josef Vagner; Liping Xu; Mark C Lloyd; Vincent M Lynch; Victor J Hruby; Jonathan L Sessler; Kevin N Sill; Robert J Gillies; David L Morse
Journal:  J Med Chem       Date:  2013-08-09       Impact factor: 7.446

9.  In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Authors:  Narges K Tafreshi; Ariosto Silva; Veronica C Estrella; Timothy W McCardle; Tingan Chen; Yolaine Jeune-Smith; Mark C Lloyd; Steven A Enkemann; Keiran S M Smalley; Vernon K Sondak; Josef Vagner; David L Morse
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

10.  Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Narges K Tafreshi; Xuan Huang; Valerie E Moberg; Natalie M Barkey; Vernon K Sondak; Haibin Tian; David L Morse; Josef Vagner
Journal:  Bioconjug Chem       Date:  2012-11-27       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.